 Kara Mould
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sequence Analysis, RNA | 6 | 2025 | 444 | 1.440 |
Why?
| | Macrophages, Alveolar | 6 | 2024 | 372 | 1.420 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2024 | 633 | 1.290 |
Why?
| | Acute Lung Injury | 4 | 2018 | 300 | 1.080 |
Why?
| | Bronchoalveolar Lavage | 1 | 2024 | 92 | 0.860 |
Why?
| | Macrophages | 8 | 2024 | 1478 | 0.780 |
Why?
| | Pneumonia | 5 | 2023 | 634 | 0.780 |
Why?
| | Pulmonary Alveoli | 2 | 2021 | 391 | 0.650 |
Why?
| | Gene Expression Profiling | 4 | 2025 | 1761 | 0.620 |
Why?
| | Monocytes | 2 | 2023 | 544 | 0.590 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 571 | 0.560 |
Why?
| | Inflammation | 8 | 2023 | 2840 | 0.510 |
Why?
| | Biomarkers | 2 | 2024 | 4180 | 0.410 |
Why?
| | Sepsis | 1 | 2018 | 627 | 0.360 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 490 | 0.310 |
Why?
| | Pulmonary Fibrosis | 2 | 2024 | 389 | 0.270 |
Why?
| | Single-Cell Analysis | 2 | 2025 | 341 | 0.230 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5866 | 0.230 |
Why?
| | Lung | 3 | 2024 | 4051 | 0.220 |
Why?
| | Healthy Volunteers | 2 | 2022 | 212 | 0.210 |
Why?
| | Folate Receptor 2 | 1 | 2023 | 8 | 0.200 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 15 | 0.180 |
Why?
| | Cytophagocytosis | 1 | 2022 | 5 | 0.180 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2022 | 49 | 0.180 |
Why?
| | Polyamines | 1 | 2022 | 43 | 0.180 |
Why?
| | Lung Injury | 1 | 2024 | 221 | 0.180 |
Why?
| | Cardiovascular System | 1 | 2023 | 137 | 0.180 |
Why?
| | Bleomycin | 2 | 2024 | 239 | 0.170 |
Why?
| | Granuloma | 1 | 2021 | 97 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2023 | 1220 | 0.170 |
Why?
| | Racism | 1 | 2023 | 141 | 0.160 |
Why?
| | Patient Positioning | 1 | 2021 | 71 | 0.160 |
Why?
| | Lipopolysaccharides | 5 | 2024 | 854 | 0.160 |
Why?
| | Animals | 12 | 2024 | 37328 | 0.160 |
Why?
| | Mice | 8 | 2024 | 17969 | 0.160 |
Why?
| | Software | 1 | 2025 | 675 | 0.160 |
Why?
| | Arginase | 1 | 2019 | 27 | 0.150 |
Why?
| | Cholestenes | 1 | 2018 | 5 | 0.150 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2019 | 171 | 0.140 |
Why?
| | RNA Precursors | 1 | 2020 | 156 | 0.140 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2019 | 88 | 0.140 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.140 |
Why?
| | RNA Splicing | 1 | 2020 | 271 | 0.140 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 20 | 0.140 |
Why?
| | CD11 Antigens | 1 | 2018 | 30 | 0.140 |
Why?
| | Interferon-beta | 1 | 2018 | 93 | 0.140 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 207 | 0.140 |
Why?
| | Humans | 18 | 2025 | 141284 | 0.130 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2017 | 38 | 0.130 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 325 | 0.130 |
Why?
| | Cytokines | 3 | 2023 | 2079 | 0.130 |
Why?
| | Gene Regulatory Networks | 1 | 2019 | 309 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2017 | 73 | 0.120 |
Why?
| | Histones | 1 | 2021 | 641 | 0.120 |
Why?
| | Gene Deletion | 1 | 2018 | 384 | 0.120 |
Why?
| | CD11b Antigen | 1 | 2016 | 62 | 0.120 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 227 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2021 | 689 | 0.120 |
Why?
| | Shock, Septic | 1 | 2018 | 214 | 0.120 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 66 | 0.120 |
Why?
| | Phagocytosis | 1 | 2017 | 291 | 0.120 |
Why?
| | Phagocytes | 1 | 2016 | 83 | 0.120 |
Why?
| | Cell Lineage | 1 | 2017 | 352 | 0.120 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2017 | 226 | 0.120 |
Why?
| | Sex Factors | 1 | 2021 | 2055 | 0.110 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1362 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2017 | 507 | 0.110 |
Why?
| | Proto-Oncogene Proteins | 1 | 2017 | 621 | 0.110 |
Why?
| | Male | 9 | 2024 | 70140 | 0.100 |
Why?
| | Antioxidant Response Elements | 1 | 2013 | 7 | 0.100 |
Why?
| | Antigens, CD | 1 | 2016 | 537 | 0.100 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2013 | 94 | 0.090 |
Why?
| | Transcriptome | 1 | 2019 | 1007 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2021 | 1996 | 0.090 |
Why?
| | Metabolomics | 1 | 2017 | 702 | 0.090 |
Why?
| | Cell Proliferation | 1 | 2017 | 2502 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2600 | 0.080 |
Why?
| | Mice, Transgenic | 3 | 2022 | 2165 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3345 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2023 | 775 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2022 | 3042 | 0.070 |
Why?
| | Female | 6 | 2022 | 75814 | 0.070 |
Why?
| | HIV-1 | 1 | 2013 | 882 | 0.070 |
Why?
| | B-Lymphocytes | 2 | 2022 | 857 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2013 | 1327 | 0.060 |
Why?
| | Eye Proteins | 1 | 2024 | 92 | 0.050 |
Why?
| | Risk Factors | 1 | 2018 | 10490 | 0.050 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 36 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 30 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 541 | 0.050 |
Why?
| | Middle Aged | 2 | 2021 | 34658 | 0.050 |
Why?
| | Spermine | 1 | 2022 | 30 | 0.050 |
Why?
| | Spermidine | 1 | 2022 | 18 | 0.050 |
Why?
| | NADPH Oxidases | 1 | 2022 | 131 | 0.040 |
Why?
| | Prone Position | 1 | 2021 | 27 | 0.040 |
Why?
| | Interferons | 1 | 2022 | 194 | 0.040 |
Why?
| | Apoptosis | 2 | 2022 | 2487 | 0.040 |
Why?
| | Immunomodulation | 1 | 2022 | 100 | 0.040 |
Why?
| | Adult | 2 | 2021 | 39319 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1009 | 0.040 |
Why?
| | Thrombin | 1 | 2021 | 166 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 364 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2023 | 303 | 0.040 |
Why?
| | RNA, Viral | 1 | 2023 | 695 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2020 | 183 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2018 | 4149 | 0.030 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 45 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2021 | 523 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2022 | 654 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1764 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2018 | 713 | 0.030 |
Why?
| | Signal Transduction | 2 | 2022 | 5116 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2023 | 674 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1113 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 816 | 0.030 |
Why?
| | Organ Specificity | 1 | 2016 | 310 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1261 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1440 | 0.030 |
Why?
| | Autoantibodies | 1 | 2022 | 1466 | 0.030 |
Why?
| | United States | 2 | 2023 | 15298 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4414 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2016 | 377 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1979 | 0.030 |
Why?
| | Sulfoxides | 1 | 2013 | 4 | 0.030 |
Why?
| | Isothiocyanates | 1 | 2013 | 4 | 0.030 |
Why?
| | Occludin | 1 | 2013 | 12 | 0.030 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2013 | 17 | 0.030 |
Why?
| | Rats, Transgenic | 1 | 2013 | 19 | 0.030 |
Why?
| | Quinones | 1 | 2013 | 9 | 0.030 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 34 | 0.030 |
Why?
| | Tight Junction Proteins | 1 | 2013 | 15 | 0.030 |
Why?
| | Thiocyanates | 1 | 2013 | 30 | 0.020 |
Why?
| | Claudins | 1 | 2013 | 24 | 0.020 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 75 | 0.020 |
Why?
| | Protein Binding | 1 | 2018 | 2233 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 465 | 0.020 |
Why?
| | Glutathione | 1 | 2013 | 361 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1490 | 0.020 |
Why?
| | Down-Regulation | 1 | 2013 | 636 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6951 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2815 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5556 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 16447 | 0.010 |
Why?
| | Aged | 1 | 2021 | 24836 | 0.010 |
Why?
|
|
Mould's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|